Log in to save to my catalogue

Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The B...

Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The B...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2741301065

Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study

About this item

Full title

Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study

Publisher

United States: Public Library of Science

Journal title

PloS one, 2022-11, Vol.17 (11), p.e0277921

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Among non-dialysis-dependent chronic kidney disease (ND-CKD) patients, a low hematopoietic response to erythropoiesis-stimulating agents (ESAs) is a predictor for poor renal and cardiovascular outcome. To assess the method for evaluating hyporesponsiveness to ESA in patients with ND-CKD, a multicenter, prospective, observational study of 1,980 adul...

Alternative Titles

Full title

Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2741301065

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2741301065

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0277921

How to access this item